Rare case of ER positive colorectal stricture demonstrating improvement with letrozole
- PMID: 22674946
- PMCID: PMC3229335
- DOI: 10.1136/bcr.09.2011.4740
Rare case of ER positive colorectal stricture demonstrating improvement with letrozole
Abstract
The authors present a rare case of a patient with an estrogen receptor (ER) positive malignant colorectal stricture, with no identifiable primary breast carcinoma. There was demonstrated endoscopic and symptomatic improvement after treatment with letrozole. Gastrointestinal metastases from breast cancer usually present with a previous history of breast cancer, however our patient had no prior or current proven history of breast cancer. Biopsy and immunohistochemical staining of the malignant colonic lesion showed an adenocarcinoma with positive ER staining. Mammogram, breast ultrasound and MRI of the breasts were all negative. She was successfully treated with letrozole for 3 years that resulted in endoscopic and symptomatic improvement in her colorectal stricture.
Conflict of interest statement
Figures


Similar articles
-
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.J Clin Oncol. 2001 Sep 15;19(18):3808-16. doi: 10.1200/JCO.2001.19.18.3808. J Clin Oncol. 2001. PMID: 11559718 Clinical Trial.
-
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole.J Clin Oncol. 2006 Jul 1;24(19):3019-25. doi: 10.1200/JCO.2005.04.3034. Epub 2006 Jun 5. J Clin Oncol. 2006. PMID: 16754938
-
Clinical response to primary letrozole therapy in elderly patients with early breast cancer: possible role for p53 as a biomarker.Int J Surg. 2014;12(8):821-6. doi: 10.1016/j.ijsu.2014.06.009. Epub 2014 Jul 8. Int J Surg. 2014. PMID: 25010604
-
Letrozole for the management of breast cancer.Expert Rev Anticancer Ther. 2002 Jun;2(3):249-60. doi: 10.1586/14737140.2.3.249. Expert Rev Anticancer Ther. 2002. PMID: 12113048 Review.
-
Anti-tumor effects of letrozole.Cancer Invest. 2002;20 Suppl 2:15-21. doi: 10.1081/cnv-120014882. Cancer Invest. 2002. PMID: 12442345 Review.
References
-
- PubMed (2011) Colon malignancy letrozole [Online] http://www.ncbi.nlm.nih.gov/pubmed?term=colon%20malignancy%20letrozole (accessed on 9 May 2011).
-
- Savanis G, Simatos G, Tzaida O, et al. Gastrointestinal tract metastasis as first presentation of breast cancer. J BUON 2006;11:79–81 - PubMed
-
- Pappo I, Stahl-Kent V, Sandbank J, et al. Gastrointestinal carcinomas occurring in breast cancer patients. Breast Journal 2006;12:437–41 - PubMed
-
- Odzak A, Geliberti F, Farace G, et al. [Pancreatic tumor: an unusual presentation of an occult breast carcinoma]. Acta Gastroenterol Latinoam 2001;31:395–8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical